FTC Warns 24 Major Health Systems Over Price Transparency
The FTC issued warning letters to 24 large health systems over price transparency compliance.
Why it matters: Healthcare pricing often lacks clarity, causing financial strain on patients. These warnings signal tighter regulatory scrutiny, urging legal and compliance teams to ensure adherence and avoid penalties.
- On October 5, 2026, the FTC sent letters to 24 major health systems about their price transparency obligations.
- The letters stress that undisclosed or misleading pricing may violate Section 5 of the FTC Act as unfair or deceptive practices.
- Compliance with CMS price transparency rules does not shield companies from FTC Act liability.
- The FTC did not reveal the names of the health systems receiving these letters.
On October 5, 2026, the Federal Trade Commission (FTC) directly warned 24 of the nation’s largest healthcare services providers about their legal duties to offer patients clear, timely, and complete pricing information for healthcare services. The FTC emphasized that failing to disclose transparent prices, especially for routine and non-emergency procedures scheduled in advance, may amount to unfair or deceptive acts under Section 5 of the FTC Act.
FTC Chairman Andrew N. Ferguson noted, “Healthcare is among the largest and most consequential expenses American families face, yet patients are routinely asked to commit to care without knowing what it will cost and with prices for the same service often differing dramatically from one facility to the next.” He reiterated that compliance with CMS's price transparency regulations alone does not provide a safe harbor against FTC enforcement.
This heightened scrutiny comes amid broader regulatory efforts aimed at empowering consumers with pricing clarity to make informed healthcare decisions and promoting fair competition among providers. The FTC’s action underscores that legal and compliance teams at major health systems must ensure that pricing disclosures are accurate and comprehensive to avoid potential liability and penalties.
While the FTC has not publicly disclosed the identities of the 24 health systems receiving these letters, the move signals increased regulatory attention on price transparency in the healthcare sector.
By the numbers:
- 24 — number of major health systems warned by the FTC
- October 5, 2026 — date the warning letters were issued
What's next: Health systems will need to review and likely enhance their pricing disclosures to comply fully with FTC expectations and avoid enforcement actions.